Management of Coronary Calcified Nodules: A Position Statement
39 affiliations
- 1Department of Cardiology, Cardiovascular Institute, The First Affiliated Hospital of Harbin Medical University, Harbin, China
- 2Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
- 3Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey
- 4Department of Internal Medicine, Xiamen Chang Gung Memorial Hospital, Xiamen, China
- 5Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
- 6Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 7Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- 8Department of Cardiovascular Medicine, Sapporo Cardiovascular Clinic, Sapporo Heart Center, Sapporo, Japan
- 9Department of Cardiology, Oita Cardiovascular Hospital, Oita, Japan
- 10Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China
- 11Departments of Cardiology and Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China
- 12Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
- 13Department of Cardiology, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- 14Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China
- 15Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China
- 16Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore
- 17Department of Cardiology, Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan
- 18Cardiovascular Research Foundation, New York, New York, USA
- 19Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China
- 20Department of Cardiology and Vascular Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
- 21Department of Cardiology, The People's Hospital of Liaoning Province, Shenyang, China
- 22Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, China
- 23Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
- 24Department of Cardiovascular Medicine, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
- 25Department of Cardiology, China-Japan Friendship Hospital, Beijing, China
- 26Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- 27Department of Cardiology, Apollo Hospital, Chennai, India
- 28Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, China
- 29Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China
- 30Division of Cardiology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
- 31Faculty of Medicine, University of Malaya, Kuala Lumper, Malaysia
- 32Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China
- 33Department of Cardiology, Shuangyashan Shuangkuang Hospital, Shuangyashan, Heilongjiang, China
- 34Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China
- 35Division of Cardiology, Qingdao Cardiovascular Hospital, Qingdao, China
- 36Jordan cardiac society& Department of Cardiology, The University of Jordan, Amman, Jordan
- 37Department of Interventional Radiology, National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russian Federation
- 38Department of Interventional Cardiology, Central Clinical Hospital, Novosibirsk, Russian Federation
- 39Cardiology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
Abstract
Coronary calcified nodules are an uncommon but important substrate for acute coronary syndromes, stent underexpansion, and recurrent target lesion revascularization. This consensus integrates pathologic, imaging, prognostic, and interventional evidence to guide practical decision-making. Intravascular imaging is essential for diagnosis, mechanism definition, and procedural optimization. Optical coherence tomography provides superior assessment of cap disruption and thrombus, whereas intravascular ultrasound remains valuable when contrast exposure or lesion crossing limits optical coherence tomography. Treatment should be tailored to lesion crossability, calcium distribution, and the need for mechanical scaffolding. No calcium-modification device or drug-eluting stent vs drug-coated balloon strategy has demonstrated consistent superiority. The proposed type IIa/IIb framework is hypothesis-generating and requires prospective validation. Calcified nodule-related target lesion failure should be managed by correcting the dominant mechanical mechanism before antiproliferative therapy. These recommendations emphasize individualized, imaging-guided percutaneous coronary intervention and identify priorities for prospective comparative research.
Related
- Position Statement by the Saudi Heart Failure Working Group of the Saudi Heart Association on the Management of Advanced Heart Failure in Saudi Arabia.
- Management of Obesity in Special Populations and Limited-Resource Settings: An Egyptian Medical Position Statement.
- Two Eruptive Calcified Nodules in the Same Artery.
- Multiple Calcified Nodules Associated With 3 Temporally Distinct Myocardial Infarctions
- Intra-aortic Balloon Counterpulsation-Assisted Cardiac Support in the Anesthetic Management of Surgery for Acute Cervical Spine Compression With Severe Coronary Artery Disease in the Prone Position
BibTeX
@article{yangcao2026management,
title = {{Management of Coronary Calcified Nodules: A Position Statement}},
author = {Yang Cao, MD and Dingyu Wang, MD and Achmad Fauzi Yahya, MD and Mehmet Ali Oto, MD, PhD and Chiung-Jen Wu, MD and Yue Wu, MD and Xiang Cheng, MD and Yong Zeng, MD and Yongtai Gong, MD and Shoichi Kuramitsu, MD, PhD and Yoshifumi Kashima, MD and Jinwei Tian, MD and Zhiren Zhang, MD, PhD and Haibo Jia, MD and Shengxian Tu, MD and Lei Song, MD and Wenqi Zhang, MD and Xiao Wang, MD and Chenguang Li, MD and Chee Yang Chin, MD, MSc and Tetsumin Lee, MD, PhD and Mitsuaki Matsumura, BS and Danghui Sun, MD and Tiankai Li, MD and Mingyou Zhang, MD and Ahmed Kassem, MD and Guo Dong, MD and Jianqiang Li, MD and Bo Luan, MD and Ho Lam, MBChB and Fei Ye, MD and Md Misbahul Ferdous, PhD and Nanhu Quan, MD and Ran Zhang, MD and Jingang Zheng, MD and Yong He, MD and Dong Yin, MD and Vijayakumar Subban, MD and Jing Li, MD and Yongle Li, MD and Yunpeng Shang, MD and Kok Han Chee, MBBS, MMed and Zaixin Yu, MD and Ye Zhu, MD and Hui Li, MD and Pengwei Song, BM and Yida Tang, MD and Changhong Lu, MD and Jamal Dabbas, MD and Firdavs Shukurov, MD, PhD and Evgeny I. Kretov, MD, PhD and Gary S. Mintz, MD and Kai-Hang Yiu, MD, PhD and Kefei Dou, MD and Yue Li, MD},
journal = {JACC: Asia},
year = {2026},
month = nov,
doi = {10.1016/j.jacasi.2026.08.029},
url = {https://doi.org/10.1016/j.jacasi.2026.08.029},
note = {CC BY},
}
RIS
TY - JOUR
TI - Management of Coronary Calcified Nodules: A Position Statement
AU - Yang Cao, MD
AU - Dingyu Wang, MD
AU - Achmad Fauzi Yahya, MD
AU - Mehmet Ali Oto, MD, PhD
AU - Chiung-Jen Wu, MD
AU - Yue Wu, MD
AU - Xiang Cheng, MD
AU - Yong Zeng, MD
AU - Yongtai Gong, MD
AU - Shoichi Kuramitsu, MD, PhD
AU - Yoshifumi Kashima, MD
AU - Jinwei Tian, MD
AU - Zhiren Zhang, MD, PhD
AU - Haibo Jia, MD
AU - Shengxian Tu, MD
AU - Lei Song, MD
AU - Wenqi Zhang, MD
AU - Xiao Wang, MD
AU - Chenguang Li, MD
AU - Chee Yang Chin, MD, MSc
AU - Tetsumin Lee, MD, PhD
AU - Mitsuaki Matsumura, BS
AU - Danghui Sun, MD
AU - Tiankai Li, MD
AU - Mingyou Zhang, MD
AU - Ahmed Kassem, MD
AU - Guo Dong, MD
AU - Jianqiang Li, MD
AU - Bo Luan, MD
AU - Ho Lam, MBChB
AU - Fei Ye, MD
AU - Md Misbahul Ferdous, PhD
AU - Nanhu Quan, MD
AU - Ran Zhang, MD
AU - Jingang Zheng, MD
AU - Yong He, MD
AU - Dong Yin, MD
AU - Vijayakumar Subban, MD
AU - Jing Li, MD
AU - Yongle Li, MD
AU - Yunpeng Shang, MD
AU - Kok Han Chee, MBBS, MMed
AU - Zaixin Yu, MD
AU - Ye Zhu, MD
AU - Hui Li, MD
AU - Pengwei Song, BM
AU - Yida Tang, MD
AU - Changhong Lu, MD
AU - Jamal Dabbas, MD
AU - Firdavs Shukurov, MD, PhD
AU - Evgeny I. Kretov, MD, PhD
AU - Gary S. Mintz, MD
AU - Kai-Hang Yiu, MD, PhD
AU - Kefei Dou, MD
AU - Yue Li, MD
PY - 2026
DA - 2026/11/05
JO - JACC: Asia
DO - 10.1016/j.jacasi.2026.08.029
UR - https://doi.org/10.1016/j.jacasi.2026.08.029
AB - Coronary calcified nodules are an uncommon but important substrate for acute coronary syndromes, stent underexpansion, and recurrent target lesion revascularization. This consensus integrates pathologic, imaging, prognostic, and interventional evidence to guide practical decision-making. Intravascular imaging is essential for diagnosis, mechanism definition, and procedural optimization. Optical coherence tomography provides superior assessment of cap disruption and thrombus, whereas intravascular ultrasound remains valuable when contrast exposure or lesion crossing limits optical coherence tomography. Treatment should be tailored to lesion crossability, calcium distribution, and the need for mechanical scaffolding. No calcium-modification device or drug-eluting stent vs drug-coated balloon strategy has demonstrated consistent superiority. The proposed type IIa/IIb framework is hypothesis-generating and requires prospective validation. Calcified nodule-related target lesion failure should be managed by correcting the dominant mechanical mechanism before antiproliferative therapy. These recommendations emphasize individualized, imaging-guided percutaneous coronary intervention and identify priorities for prospective comparative research.
SN - 2772-3747
ER -